Literature DB >> 30605157

To win at gene therapy, companies pick viruses with production credentials.

Cormac Sheridan.   

Abstract

Mesh：

Year:  2019        PMID： 30605157     DOI： 10.1038/nbt0119-5

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  FDA approves hereditary blindness gene therapy.

Authors: 
Journal:  Nat Biotechnol       Date:  2018-01-10       Impact factor: 54.908
  1 in total
  1 in total

Review 1.  Mucopolysaccharidoses type I gene therapy.

Authors:  Sarah C Hurt; Patricia I Dickson; David T Curiel
Journal:  J Inherit Metab Dis       Date:  2021-07-09       Impact factor: 4.750
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.